Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial.
Gelman R, Hurvitz N, Nesserat R, Kolben Y, Nachman D, Jamil K, Agus S, Asleh R, Amir O, Berg M, Ilan Y. Gelman R, et al. Biomed Pharmacother. 2023 May;161:114334. doi: 10.1016/j.biopha.2023.114334. Epub 2023 Mar 9. Biomed Pharmacother. 2023. PMID: 36905809 Free article. Clinical Trial.
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial.
Ishay Y, Neutel J, Kolben Y, Gelman R, Arbib OS, Lopez O, Katchman H, Mohseni R, Kidron M, Ilan Y. Ishay Y, et al. Among authors: gelman r. Gastro Hep Adv. 2023 Dec 7;3(3):417-425. doi: 10.1016/j.gastha.2023.11.016. eCollection 2024. Gastro Hep Adv. 2023. PMID: 39131144 Free PMC article.
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial.
Sigawi T, Gelman R, Maimon O, Yossef A, Hemed N, Agus S, Berg M, Ilan Y, Popovtzer A. Sigawi T, et al. Among authors: gelman r. Front Oncol. 2024 Jul 30;14:1426426. doi: 10.3389/fonc.2024.1426426. eCollection 2024. Front Oncol. 2024. PMID: 39139285 Free PMC article.
368 results